Stocks · News reference

eXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery

Jun 24, 2026, 8:15 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 18, 2026, 8:32 PMBenzinga Newsdesk
eXoZymes Says Optimized NCT Process Delivered 10-Fold Productivity Gain vs. 100-Liter Pilot, With About 67% More Output Per Liter
Read original at benzinga
EXOZ
BenzingaJul 23, 2026, 8:25 PMBenzinga Newsdesk
eXoZymes Selected To Participate In Inaugural U.S. DOE Genesis Mission; Co. To Collaborate With Lawrence Berkeley National Laboratory On AI-Enabled Digital Twins For Cell-Free Biomanufacturing
Company to collaborate with Lawrence Berkeley National Laboratory on AI-enabled digital twins designed to accelerate optimization of enzyme-driven manufacturing processes.The 9-month project awarded approximately
Read original at benzinga
EXOZ
SEC EDGARJul 1, 2026, 8:30 PMSEC EDGAR
8-K filing — EXOZYMES INC. (EXOZ)
Filed: 2026-07-01 AccNo: 0001493152-26-031560 Size: 571 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Read original at edgar
EXOZ